J&J: Application to EMA for New Indication Approval for Imbruvica in Adults With Previously Untreated Mcl Eligible for Autologous Stem Cell Transplant
強生:向歐洲藥品管理局申請對接受自體幹細胞移植的成年患者使用Imbruvica的新適應症批准
J&J: Application to EMA for New Indication Approval for Imbruvica in Adults With Previously Untreated Mcl Eligible for Autologous Stem Cell Transplant
強生:向歐洲藥品管理局申請對接受自體幹細胞移植的成年患者使用Imbruvica的新適應症批准
使用瀏覽器的分享功能,分享給你的好友吧